ClinicalTrials.gg
Drug

Thalidomide clinical trials

Also written Thalomid and Kevadon.

studies test it
315
open now
19
in phase 3
66
first study started
1990

How each study uses Thalidomide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Thalidomide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Jul 1998 · THALOMID · NDA 020785 (FDA, Drugs@FDA)
European Union
16 Apr 2008 · Thalidomide BMS (previously Thalidomide Celgene) · EMEA/H/C/000823 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Thalidomide
257
THAL
15
Synovir
12
Thalidomide (100mg)
4
Thalidomide Celgene
4

Brand

Thalomid
54
Kevadon
12
Contergan
2
Softenon
2
neurosedyn
1
celgene
1

Other names

N-phthalylglutamic acid imide
1

In one entry with another drug

Given together, or one or the other

thalidomide and hydroxyurea
2
Hydroxyurea and Thalidomide
2
Thalidomide, Dexamethasone
2

Studies by the year they started

304 studies that test it; most in 2002 (31)

Studies that test Thalidomide, by start year
YearStudies
19901
19951
19962
19972
199811
199910
200021
200128
200231
200320
200416
200519
200621
200715
20086
20096
20105
20112
20127
201310
20144
20154
20168
201712
20185
20193
20206
20211
20225
20235
20247
20255
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
25
Phase 2
218
Phase 3
66
Phase 4
13
No phase
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 301

National Cancer Institute (NCI) (27) · University of Arkansas (18) · M.D. Anderson Cancer Center (10) · Memorial Sloan Kettering Cancer Center (9) · Dana-Farber Cancer Institute (8) · SWOG Cancer Research Network (7) · Institute of Hematology & Blood Diseases Hospital, China (6) · Roswell Park Cancer Institute (5)

Often tested with

Tested in the same studies.

Dexamethasone (56) · Bortezomib (27) · Cyclophosphamide (26) · Melphalan (19) · Prednisone (16) · Doxorubicin (15) · Temozolomide (13) · Etoposide (12)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Thalidomide is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 9, 1 in phase 3

Studies that test Thalidomide, phase 3 first.

Studies

Open first, then newest update. How each study uses Thalidomide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 315

See all 315 studies that test Thalidomide →

Given beside what is tested · 33 — Thalidomide is usual care or a partner of the new treatment

Showing 20 of 33.

As the comparator · 7 — what is tested is compared with Thalidomide

Codes

What other systems call Thalidomide · ClinicalTrials.gg INT008299

  • MeSH (NLM) D013792ThalidomideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4Z8R6ORS6LTHALIDOMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 10432Confirmed FDA, Wikidata
  • Wikidata Q203174thalidomideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C870ThalidomideOne source FDA
  • DrugBank DB01041One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.